n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, October 18th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Emergent Capital, Inc. (EMGC)

MarketWatch, OTC Markets, and 4-Traders reported on Emergent Capital, Inc. (EMGC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Emergent Capital, Inc. is a specialty finance company. It invests in life settlements and is a worldwide leader in the life settlements industry. Emergent Capital has decades of experience creating value by way of the secondary and tertiary markets for life insurance policies. The Company established in 2006 as Imperial Holdings, LLC. Since 2011 it has been publicly traded. Emergent Capital has its headquarters in Boca Raton, Florida.

In 2015, shareholders voted to change the Company’s name to Emergent Capital, Inc. Concerning Life settlements; they are an alternative asset class that can provide high uncorrelated returns. Emergent Capital has access to an extensive and proven network of life settlement brokers and third-party providers from whom it sources appealing and value-added policies.

For investor consideration, life settlements have limited correlation to the stock market or the larger economic market. They can serve as a hedge against the volatility of more market-dependent investments. Also, life settlements represent a compelling and diversified investment opportunity to include longevity risk in a portfolio.

Fundamentally, Emergent Capital buys individual policies and portfolios of life insurance policies. The Company manages these assets based on comprehensive actuarial and market data. In addition, an Emergent Capital subsidiary can act as a life settlement provider in greater than 30 states where it is able to pursue many opportunities within the life settlement space.

The Company’s goal is to generate a consistent flow of investment opportunities encompassing all aspects of the life settlements marketplace. These range from lending to outright purchases of portfolios, to tertiary trades, and also individual secondary market purchases.

This past August, Emergent Capital announced its financial results for the three and six month periods ended June 30, 2017. Total Income from Continuing Operations was $3.5 million for the three month period ended June 30, 2017 versus a loss of $15.8 million for the same period in 2016.

Emergent Capital reported a Net Loss from Continuing Operations of $6.5 million, or $(0.23) per diluted share for the three month period ended June 30, 2017, versus $9.8 million, or $(0.36) per diluted share for the same period the year prior.

Emergent Capital, Inc. (EMGC), closed Wednesday's trading session at $0.395, up 6.76%, on 3,500 volume with 2 trades. The average volume for the last 60 days is 85,764 and the stock's 52-week low/high is $0.189/$0.5351.

alpha-En Corp. (ALPE)

Real Pennies and Wall Street Mover reported earlier on alpha-En Corp. (ALPE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

alpha-En Corp. is a clean technology enterprise headquartered in Yonkers, New York. alpha-En concentrates on enabling next generation battery technologies through developing and bringing to market high purity lithium metal and associated products produced in an environmentally sustainable way. The Company’s lithium metal is purer than what is presently available on the market. It is free of all base metals and common non-conductive impurities found in the existing commercial supply.

alpha-En has its new, 8,000 square foot facility in Yonkers, New York. The new facility is part of the innovative iPark Hudson technology and office campus. This facility is now alpha-En’s innovation and product development center, and its global headquarters and head office.

alpha-En has strategic research partnerships with Argonne National Laboratory, Princeton University, and the City University of New York to advance commercialization and scale-up of production.

The Company’s Chairman and Founder has a proven record of identifying new technologies and bringing them to market. These include soft contact lens, surgical staples, and high silica glass to store nuclear waste, among others. alpha-En’s Scientific Team includes a Nobel Prize winning Chemist. In addition, it includes a team of dedicated researchers and management.

alpha-En enables next generation energy storage. Its focus is on room temperature production of high purity lithium metal and associated products. alpha-En’s flexible disposition method can also streamline battery manufacturing leading to battery production cost benefits.

alpha-En’s room temperature, proprietary patent pending process is mercury and chlorine free. This eliminates the use and release of toxic chemicals and expensive containment costs. Furthermore, the room temperature process requires minimal electricity, and using Lithium Carbonate as feedstock reduces the Company’s raw material costs. The process is conducted at 20°-30°C.

Recently, alpha-En announced the start of a joint research program with Mercedes-Benz Research and Development North America and Princeton University. The joint research program's investigation of alpha-En's pure lithium metal thin films in advanced battery systems will take place at Princeton University under the direction of Mr. Daniel Steingart, Associate Professor of Mechanical and Aerospace Engineering at the Andlinger Center for Energy and the Environment.

The purpose of the program is for all parties to work together using alpha-En's highly pure lithium metal Nano-rods to investigate the potential of certain next-generation battery technologies to improve cell performance and battery production for electric vehicle and consumer product applications.

Last month, alpha-En announced an award of $750,000 from the U.S. Department of Energy's Office of Technology Transition Technology Commercialization Fund (TCF). alpha-En and Argonne National Lab will advance alpha-En technology to produce lithium metal anodes for EV Batteries with the award from the DOE Technology Commercialization Fund. The funding will be used to commercialize Argonne's proprietary highly conductive solid-state electrolyte coating for alpha-En's lithium metal anodes.

alpha-En Corp. (ALPE), closed Wednesday's trading session at $3.17, up 3.59%, on 2,733 volume with 9 trades. The average volume for the last 60 days is 6,721 and the stock's 52-week low/high is $0.551/$3.54.

Black Sea Copper & Gold Corp. (BLSSF)

MarketWatch, Stockhouse, InvestorsHub, Barchart, and Investors Hangout reported on Black Sea Copper & Gold Corp. (BLSSF) and today we report on the Company, here at the QualityStocks Daily Newsletter.

Black Sea Copper & Gold Corp. is a mineral exploration company listed on the OTC Markets Group’s OTCQB. The Company is active in the Black Sea area of Eastern Europe. Black Sea’s commitment is to build a strong portfolio of high quality copper and gold projects with the potential to become world-class mining assets. Black Sea Copper & Gold has established a complement of local technical, logistical, community, and corporate support. The Company is based in Vancouver, British Columbia.

Black Sea’s mission is to quickly grow and advance a successful portfolio of projects in the West Tethyan Metallogenic Belt of Eastern Europe through discovery, acquisitions, and partnerships. Its projects include Zlatusha, Copper-Gold; and Kalabak, Copper-Gold.

Black Sea Copper & Gold has demonstrated its ability to identify new copper-gold porphyry and epithermal targets. The Company believes that it has one of the most extensive proprietary geological/exploration databases for Eastern Europe in the industry. Black Sea has over four years of regional experience technically and operationally within Bulgaria, Serbia, Turkey, and Romania.

Zlatusha is situated about 40 kilometers northwest of Sofia in western Bulgaria within the Srednogorie endowed arc segment of the West Tethyan Metallogenic Belt. The Zlatusha license area (195 km2) lies within a developing porphyry copper-gold/epithermal belt positioned northwest of Sofia. The project opportunity was identified by Black Sea Copper & Gold in July of 2013 after launching a detailed exploration campaign.

Kalabak is located roughly 10 km north of Ada Tepe in the Bulgarian Rhodope Mountains. Mineral potential at Kalabak was identified during the Company’s extensive reconnaissance exploration program in Bulgaria. Consequently, Black Sea applied for and was awarded the Kalabak license in October of 2014. The Kalabak license area (191 km2) lies within a developing porphyry copper-gold belt in the south-eastern sector of the Bulgarian Rhodope Mountains.

Black Sea’s project pipeline includes Golaka, Copper-Gold, which is around 1 km from the Assarel Mine in the Panagyurishte Cu-Au trend in central Bulgaria. In addition, the Company’s project pipeline includes Coka Njalta, Copper-Gold, situated roughly 5 km south of the Majdanpek Mine in the world-class Timok belt of eastern Serbia. Furthermore, its project pipeline includes Susulajka, Copper-Gold, located about 12 km north of Bor Mine in the world-class Timok belt of eastern Serbia.

Black Sea Copper & Gold announced this past February exploration results for its 100 percent owned Kalabak property in the Bulgarian Rhodope Mountains. Field mapping and sampling results at Kalabak confirmed the presence of a porphyry environment and discovered three new structural zones with mineralization and vein textures indicative of an epithermal environment.

Black Sea Copper & Gold Corp. (BLSSF), closed Wednesday's trading session at $0.1194, down 0.25%, on 818 volume with 5 trades. The average volume for the last 60 days is 3,334 and the stock's 52-week low/high is $0.1059/$0.2921.

Visualant, Inc. (VSUL)

PennyStocks24, Pennybuster, Wall Street Resources, Investor Ideas, Trade of the Week, Investor Guide, Wyatt Investment Research, Coattail Investor, Millennium-Traders, Wall Street Mover, Greenbackers, TopPennyStockMovers, SmallCapFinancialWire, Oakshire News Bulletin, and ChartAdvisor reported previously on Visualant, Inc. (VSUL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Visualant, Inc. is a photonics technology development company. It provides chromatic-based identification, authentication, and diagnostic solutions, with its ChromaID™ technology. The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, via a liquid, gas, or off a surface, to capture a unique ChromaID™. Listed on the OTC Markets’ OTCQB, Visualant is based in Seattle, Washington.

Intellicheck Mobilisa is the Company’s partner. Intellicheck acquired the exclusive rights to Visualant’s proprietary Spectral Pattern Matching™ (SPM™) technology for specific homeland security, law enforcement, and crime prevention applications. Intellicheck Mobilisa is an industry leader in threat identification, identity authentication, verification, and validation systems.

ChromaID technology has extensive application across industrial, medical, security, and consumer markets. Government agencies, law enforcement, and security companies can utilize ChromaIDs to authenticate secured documents, identify counterfeits, or detect illicit drugs. ChromaID is a sensor technology that has wide-ranging applications in the world of the Internet of Things (IoT).

A ChromaID can be used to identify, detect, or diagnose markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive. This makes it possible to effectively conduct analyses in the field that could only before be performed by large and expensive lab-based tests.

Additionally, ChromaID devices are portable and field-deployable and allow real-time results. Furthermore, ChromaID is available for licensing in collaboration with strategic partners for an assortment of proprietary applications and commercial needs.

Medical applications of ChromaIDs include measuring indicators of disease or health and identifying drugs. Consumers can identify colors and measure cosmetic skin factors. The ChromaID Scanner provides a low cost per scan, high speed, first-rate portability, and it is user-friendly. The ChromaID Scanner's 12 LEDs range from 355nm (ultraviolet) to 1450nm (near infra-red).

In May of this year, Visualant announced that it received its 11th U.S. patent. The invention relates to the use of its disruptive ChromaID™ technology for identifying and analyzing biological tissue. It has numerous potential applications in healthcare, food safety, cosmetics and other medical, industrial and consumer markets.

The Visualant ChromaID technology, as applied to the evaluation of biological tissue, will allow for a broad array of real-world applications involving identification and diagnostics. This includes medical diagnostics, food safety and quality control and cosmetic analysis.

Recently, Visualant announced that Mr. Phillip Bosua, a member of the Company’s Scientific Advisory Board, became Chief Product Officer of Visualant. Mr. Bosua is a globally recognized inventor and innovator. His expertise in lighting led him to found LIFX where he created the world’s first commercial smart light bulb.

Visualant, Inc. (VSUL), closed Wednesday's trading session at $0.379, even for the day, on 44 volume with 1 trade. The average volume for the last 60 days is 8,519 and the stock's 52-week low/high is $0.1089/$1.44.

PetLife Pharmaceuticals, Inc. (PTLF)

Winning Penny Stock Picks, Penny Stock Circle, 1-2-3 Stock Alerts, StockMister, Fortune Stock Alerts, RisingPennyStocks, Super Hot Penny Stocks, PennyStockMoneyTrain, WePickPennyStocks, Liquid Tycoon, Penny Stock Pick Alert, Penny Stock Pick Report, MicroCapDaily, OTCMagic, Winston Small Cap, Equity Observer, Value Penny Stocks, Jet-Life Penny Stocks, TopPennyStockMovers, PHUB News, DSR News, SixFigureStockPicks, PennyPickAlerts, Super Nova Stock Picks, Joe Penny Stocks, FOX Penny Stocks, Wall St Report, smartOTC, and OTC Markets Group reported on PetLife Pharmaceuticals, Inc. (PTLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

PetLife Pharmaceuticals, Inc. is a developer of new generation high potency veterinary cancer medications and nutraceuticals for pets. PetLife is a registered US Veterinary Pharmaceutical company. The Company is a spinoff of Medolife Corp. Its management team consists of experts and professionals in the veterinary, business, sales and management fields. PetLife Pharmaceuticals is based in Hancock, Maryland.

The Company is launching a new generation of all natural veterinary cancer medications and nutraceuticals based on the venom of the Caribbean Blue Scorpion. The underpinning of this treatment is on the same patented formula and production processes used in the human formulation called Escozine™.

PetLife Pharmaceuticals has licensed the global rights to formulate, package, and market a new product line, "Vitalzul for Pets™". Its corporate mission is to bring a number of non-invasive treatments to market with the aim of improving the quality of life in companion animals. PetLife anticipates incorporating Vitalzul™ in a new and advanced therapeutic pet food line in 2019.

Vitalzul™ was originally developed and commercialized by PetLife™, Corp. in 2007. PetLife™ received a full patent in 2012. The exclusive patent license is being utilized to produce a new generation of nutraceuticals and drugs using the polarized, potentiated bioactive peptide to cause apoptosis in malignant cells. Vitalzul™ sells in the United States as a nutraceutical.

PetLife Pharmaceuticals announced earlier this year that its subsidiary, Dr. Geoff's by PetLife, Inc., completed the acquisition of assets related to the natural pet food product line. The different trademarks supporting the Dr. Geoff's Real Food for Pets™ were obtained in exchange for common stock of PetLife Pharmaceuticals. The product line is projected to include VitalZul™ in a second generation of the product in 2018.

PetLife research has verified that scorpion venoms may also have antibacterial and anti-inflammatory properties. The PetLife research team is evaluating the potential for scorpion venom-based therapy for common companion pet diseases. This includes Lyme disease and arthritis.

PetLife Pharmaceuticals earlier reported on its solution to the ever-increasing problem of drug resistance and high toxicity in the treatment of cancer in pets and humans. Its new patent-pending formulation has created a 'cancer cocktail' combining Blue Scorpion Venom Chlorotoxin with plant-based phytonutrients. Preliminary testing has shown inhibition against certain cancer cell line studies without toxicity.

PetLife Pharmaceuticals has engaged its in-country team for the development of its PetLife Scorpion Ranch. Scorpions have been collected. Plans continue to have the ranch fully functional and extracting venom. Venom is one of the world's most precious liquids. PetLife Pharmaceuticals’ intention is to use all its production of venom on proprietary PetLife products for the treatment of cancer. The Company intends to continue research on Vitalzul™'s potential as a cancer preventative.

PetLife Pharmaceuticals, Inc. (PTLF), closed Wednesday's trading session at $0.0956, down 3.73%, on 13,250 volume with 5 trades. The average volume for the last 60 days is 135,635 and the stock's 52-week low/high is $0.08/$0.90.

Legacy Education Alliance, Inc. (LEAI)

Fortune Stock Alerts, RedChip, Marketbeat, DSR News, PHUB News, Stock Commander, and PennyPickAlerts reported earlier on Legacy Education Alliance, Inc. (LEAI), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Established in 1996, Legacy Education Alliance, Inc. is a leading international provider of practical, high-quality, and value-based educational training. This training is on the topics of personal finance, entrepreneurship, real estate, and financial markets investing strategies and techniques. The Company’s commitment is to providing quality financial education.

Legacy Educational Alliance has headquarters in the U.S., Canada, and the United Kingdom (UK). The Company is a global business and has cumulatively served more than two million students from over 150 nations and territories over the course of its operating history. Legacy Educational Alliance lists on the OTCQB. The Company’s U.S. office is in Cape Coral, Florida.

Legacy provides its training through a variety of brands. These include Trade Up Investor Education™; Rich Dad® Education; Rich Dad® Stock Education; Making Money from Property with Martin Roberts™; Brick Buy Brick™; Building Wealth; Robbie Fowler Property Academy™; Women in Wealth™; and The Independent Woman™.

The Making Money from Property with Martin Roberts™ brand provides a property-based curriculum focused on how and why to purchase property at auction. Rich Dad® Education provides students with extensive instruction and mentoring in real estate and financial instruments training in the United States, Canada, and the UK.

The Brick Buy Brick™ brand introduces its students to the tools and strategies utilized by successful investors to become financially free through real estate investing. The Trade Up Investor Education™ brand underwent development in partnership with Investor's Business Daily®. Students are provided educational training designed to help them build their knowledge of stock and options trading.

The design of Robbie Fowler Property Academy™ is to teach investment strategies people can use to achieve a clear path towards long-term wealth. The Independent Woman™ is a leader in the effort to provide educational training, seminars, and services designed to help women build their financial intelligence.

The Rich Dad® Stock Education training brand helps its students in becoming astute investors who understand how to create winning trades and potential profits in any market condition. The Women In Wealth™ brand seeks to empower women with a strong financial education and help them in discovering the power of real estate investing to produce cash flow and build financial independence.

Recently, Legacy Education Alliance announced financial results for the three months and six months ended June 30, 2017. Revenue was $24.8 million for the quarter ended June 30, 2017 versus $23.4 million for the quarter ended June 30, 2016. This represents an increase of $1.4 million or 6.0 percent.

Net Income was $1.0 million or $0.04 per basic and diluted common share for the quarter ended June 30, 2017. This is consistent with Net Income of $1.0 million or $0.05 per basic and $0.04 diluted common share for the quarter ended June 30, 2016.

Legacy Education Alliance, Inc. (LEAI), closed Wednesday's trading session at $0.40, up 5.26%, on 10,000 volume with 1 trade. The average volume for the last 60 days is 11,673 and the stock's 52-week low/high is $0.17/$0.48.

Semler Scientific, Inc. (SMLR)

Wall Street Resources, Marketbeat, Money Morning, and Barchart reported earlier on Semler Scientific, Inc. (SMLR), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Semler Scientific, Inc. is a medical risk-assessment company. Its mission is to develop, manufacture, and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Semler Scientific provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups. OTCQB-listed, Semler Scientific has its headquarters in Portland, Oregon.

In essence, Semler Scientific provides diagnostic and testing services to the U.S.’s foremost health plans and providers. The Company’s goal is to develop, manufacture, and market innovative proprietary products and services that assist its customers in evaluating and treating chronic diseases.

Semler’s diagnostic and testing products and services assist in guiding patient care. They close the gap between the cost of care and compensation for care.

Semler Scientific manufactures the QuantaFlo™ system for Vascular Disease testing. The QuantaFlo™ system is very suitable for use in primary care offices, specialty practices, health fairs, or during home assessments.

The QuantaFlo™ PAD test delivers quick, accurate results in roughly five minutes at the point of care. In March of 2015, Semler Scientific received Food and Drug Administration (FDA) 510(k) clearance for the next generation version of QuantaFlo™, which commercially launched in August 2015.

Moreover, Semler Scientific has its WellChec™ service. WellChec™ is a service providing turn-key assessment testing across the United States for an array of conditions. It provides turnkey solutions for administering important clinical tests that can impact HCC classifications, CPT coding, HEDIS and Quality Measures. The Company launched its multi-test service platform, WellChec™ in April 2015.

This past August, Semler Scientific reported financial results for Q2 and six months ended June 30, 2017. For the three months ended June 30, 2017, versus the corresponding period of 2016, Semler Scientific had Revenue of $2,578,000. This represents an increase of $942,000, versus $1,636,000. The Company had a Net Loss of $850,000, or $0.16 per share. This represents a decrease of $116,000, versus a Net Loss of $966,000, or $0.19 per share.

For the six months ended June 30, 2017, versus the corresponding period of 2016, the Company had Revenue of $4,633,000. This represents an increase of $1,497,000, versus $3,136,000. Semler had a Net Loss of $1,722,000, or $0.33 per share, a decrease of $250,000, versus a net loss of $1,972,000, or $0.38 per share.

Semler Scientific, Inc. (SMLR), closed Wednesday's trading session at $5.60, up 0.18%, on 1,601 volume with 8 trades. The average volume for the last 60 days is 4,405 and the stock's 52-week low/high is $1.28/$5.74.

graphic

The QualityStocks
Company Corner

graphic
graphic

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $0.69, even for the day, on 228,407 volume with 147 trades. The stock’s average daily volume over the past 60 days is 6,080, and its 52-week low/high is $0.69/$5.45.

EVIO, Inc. (EVIO), the nation's leading provider of analytical laboratory cannabis testing, research and advisory services, announces its EVIO Labs division has already exceeded last October's Testing Revenues through the first half of October 2017 with sales surpassing $250,000.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO Labs Sees Demand for Testing Services Double

EVIO, Inc. (EVIO) is “One to Watch”

EVIO Labs to Provide Accredited Industrial Hemp Testing in Oregon

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.19, up 5.56%, on 549,275 volume with 161 trades. The stock’s average daily volume over the past 60 days is 53,372 and its 52-week low/high is $0.0711/$0.2419.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Tapinator, Inc. (TAPM), a client of NNW that develops and publishes mobile games on the iOS, Google Play and Amazon platforms. The publication, titled, "These 5 Mobile Gaming Stocks Aren't Playing Around," discusses several public mobile gaming companies grabbing their share of the growing gaming industry. To view the full publication, visit: https://www.networknewswire.com/5-mobile-gaming-stocks-arent-playing-around/

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

NetworkNewsWire Announces Publication Discussing Competitive Companies in the Global Gaming Market

Tapinator Announces Major Update of Hit Game Dice Mage 2

Tapinator, Inc. (TAPM) is “One to Watch”

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.09, off by 6.35%, on 250 volume with 1 trade. The stock’s average daily volume over the past 60 days is 15,416 and its 52-week low/high is $0.019/$0.20.

Greenkraft, Inc. (GKIT), a nationally recognized player in the alternative fuel engine and vehicle market, today announces that the company's 8L V8 Gasoline, CNG, and LPG fuel-injected engine received new certification from the California Air Resources Board's "On-Road New Vehicle and Engine Certification Program."

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

Greenkraft, Inc.'s (GKIT) Alternative Fuel Engine Awarded Certification for Exceeding California's Clean Air Act Standards

Greenkraft, Inc. Expands Distribution Network to Meet Increased Product Demand

Greenkraft, Inc. (GKIT) Engages NetworkNewsWire for Corporate Communications Solutions

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.5792, up 13.35%, on 19,202 volume with 11 trades. The stock’s average daily volume over the past 60 days is 61,947 and its 52-week low/high is $0.20/$2.09.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Announces Additional Deployment of Disruptive Surgical Information Software at Three Leading Hospitals in Southern California

ORHub, Inc. Appoints Industry-Leading Neurosurgeon and Orthopedic Surgeon to Advisory Board

ORHub, Inc. Welcomes Internationally Recognized Spine Surgeon to its Advisory Board

Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB:PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $1.23, up 9.82%, on 247,422 volume with 170 trades. The stock’s average daily volume over the past 60 days is 142,974, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One Technologies Inc. Announces an Increase to the Previously Announced Bought Deal Financing

Patriot One Technologies Inc. Announces $8.5 Million Bought Deal

Patriot One Technologies Inc. Announces Listing of Warrants

92 Resources Corp. (TSX.V:NTY) (OTCQB:RGDCF) (FSE:R9G2)

The QualityStocks Daily Newsletter would like to spotlight 92 Resources Corp. (RGDCF). Today, 92 Resources Corp. closed trading at $0.082, up 9.19%, on 7,101 volume with 5 trades. The stock’s average daily volume over the past 60 days is 23,661 and its 52-week low/high is $0.071/$0.1318.

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) is a modern energy solutions company focused on acquiring and advancing strategic and prospective energy-related projects in Canada. Its three principal assets include the Hidden Lake Lithium Property in the Northwest Territories, the Pontax Lithium Property in Quebec, and the Golden Frac Sand Property in British Columbia.

Preliminary mineralogy work on samples taken of the Hidden Lake pegmatites indicate spodumene – the world's richest source of lithium – is of a high quality and near the maximum theoretical limit. Scoping testwork saw an overall lithium extraction of 97 percent from the concentrate produced from these pegmatites, which means standard lithium extraction techniques can be applied, making the extraction of lithium easier and more cost effective.

92 Resources is focused on developing the lithium-rich resources located within its properties through open-pit mining and relatively straight-forward mineral processing procedures. Surface exploration programs that include prospecting, mapping and sampling of known spodumene-bearing pegmatites on the Hidden Lake property suggests the existence of one massive, interconnected body of pegmatite below the surface. Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio.

Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio. The properties, known as Corvette, Eastmain and Lac Du Beryl, consist of a combined 115 mineral claims totaling approximately 14,710 acres with confirmed pegmatite outcrops visible at each location. Some sampling has been completed at the Corvette property and shows spodumene crystals present, making this location a high priority for follow up work. Analytical results are pending on samples taken from known pegmatite outcrops visible at each property.

Lithium is a strategic, green metal used in batteries, electronics, electric vehicles, ceramics, alloys, lubricants and pharmaceuticals. The world market for electric vehicles, with China as its biggest customer, is exponentially growing as the demand for clean, renewable energy sources increases. A recent report by Grand View Research, Inc. places the lithium-ion battery market worldwide at $93 billion by 2025, with a compound annual growth rate of 17%.

92 Resources is led by an experienced management team and advisors with decades of expertise in market strategies, corporate development, mineral exploration and energy development. With an excellent team of professionals and promising mining projects, the company is well positioned to capitalize on the ever-rising demand for lithium. Disclaimer

92 Resources Corp. Blog

92 Resources Corp. News:

NetworkNewsWire Announces Publication Discussing the Impact of Lithium Demand on Several Public Companies

Lithium, Fuelling the New Millennium

92 Resources Corp. Acquires Three New Properties in Quebec

Bollente Companies, Inc. (BOLC)

The QualityStocks Daily Newsletter would like to spotlight Bollente Companies, Inc. (BOLC). Today, Bollente Companies, Inc. closed trading at $0.85, even for the day. The stock’s average daily volume over the past 60 days is 633 and its 52-week low/high is $0.20/$1.21.

Bollente Companies, Inc. (BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under "trutankless", a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.

The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.

The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente's trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.

By maintaining 99 percent efficiency, Bollente's trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system's self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.

Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.

Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers. Disclaimer

Bollente Companies, Inc. Blog

Bollente Companies, Inc. News:

Bollente Companies' trutankless® Partners with Ferguson for Nationwide Distribution Program

Bollente Companies Increases Production and Distribution Capabilities for trutankless® with Global Manufacturing Partnership

Bollente Companies Increases Presence in Trending Segment of Commercial Construction with Its Smart trutankless Product Line

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketBeat
(DRWIQ) +50.00%

2.

StockMarketWatch
(SPPI) +36.03%

3.

Barchart
(CREE) +16.43%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251